Rare
lephants
Screener
Toggle theme
Allogene Therapeutics, Inc.
ALLO
·
Healthcare, Drug Manufacturers - General, United States
Analysis
Financial Statements
Profitability
Balance Sheet
Cash Flow
Price Ratios
Share-Based Metrics
Valuation
Profit History
Revenue Breakdown
Profit Flow
Profit Margins
Returns on Capital
Profitability
›
Revenue Breakdown
←
5Y
10Y
MAX
→
Revenue Breakdown
Chart
Table
Fiscal Year
Collaboration Revenue
FY2024
$22.0K
FY2025
$0
Download CSV
